PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hormone therapy increases invasive breast cancer and mortality, WHI 11-year follow up finds

UB to manage $8.2 million to fund new round of WHI studies

2010-10-21
(Press-News.org) BUFFALO, N.Y. -- Results of a new Women's Health Initiative (WHI) report show that hormone therapy is associated with an increased the risk of death from breast cancer, as well as an increased risk of developing invasive breast cancer in postmenopausal women. Jean Wactawski-Wende, PhD, professor of social and preventive medicine at the University at Buffalo and one of the primary authors on the paper, published today in JAMA, says the breast cancers found in these women also tended to have more lymph node involvement, indicating a poorer prognosis. "This report, which expands on earlier results of the WHI study, followed these women for an average of 11 years," says Wactawski-Wende. "The data show that, with further follow-up, there remains an increased incidence of breast cancer in women taking estrogen plus progestin. "In fact, women taking estrogen plus progestin are more likely to die from breast cancer and from other causes than women who did not take these hormones." The paper was posted online Oct. 19 at http://jama.ama-assn.org/cgi/reprint/304/15/1684. Wactawski-Wende was co-PI at UB's WHI Vanguard Center, one of 16 that helped develop the initial protocols for the study, which began in 1993 and eventually included 40 clinical centers across the U.S. Initially planned to continue until 2005, the hormone trial was halted in 2002 because preliminary analysis of the data showed estrogen plus progestin increased the risk of heart disease, stroke and invasive breast cancer. Prior to WHI, scientists speculated that hormone therapy reduced heart disease risk. The WHI continued to follow these women after the main trial ended. The current JAMA paper reports the results of research conducted during this WHI extension phase. Most of the earlier observational studies, which follow participants over time and collect health information at specific intervals, had suggested that breast cancers that develop in women taking hormone therapy were less advanced and had a lower risk of death. However, the WHI researchers note in the JAMA paper that the influence of estrogen plus progestin on breast cancer mortality had not been addressed in the context of a randomized clinical trial, prior to WHI. Their current study to answer that question was based on 12,788 surviving postmenopausal women who took part in the initial trial. Results showed that combined hormone therapy increases the incidence of invasive breast cancer and that, more commonly, the cancers had spread to the lymph nodes. There also were more deaths attributed to breast cancer in those taking hormone therapy -- 2.6 versus 1.3 per 10,000 women. There also were more deaths from all causes in the women who had been diagnosed with breast cancer who were on hormone therapy -- 5.3 versus 3.4 per 10,000. The trial also found that hormone therapy interfered with detection of breast cancer, leading to cancers being diagnosed at a more advanced stage. "These findings related to increased mortality in estrogen plus progestin users were surprising," says Wactawski-Wende. "Prior studies had suggested that, although these women were diagnosed with breast cancer, their prognosis was more positive than those who were not on hormone therapy when diagnosed. This study emphasizes the importance of clinical trial data to understand the risks and benefits of taking hormone therapy." INFORMATION:

Wactawski-Wende will oversee the next five-year round of WHI studies carried out by the nine original WHI research centers in the Northeast, funded by an $8.2 million award to UB from the National Heart, Lung and Blood Institute. Rowan T. Chlebowski, MD, PhD, from Harbor-UCLA Medical Center, is principal author on this report.

The University at Buffalo is a premier research-intensive public university, a flagship institution in the State University of New York system and its largest and most comprehensive campus. UB's more than 28,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.



ELSE PRESS RELEASES FROM THIS DATE:

The real 'mommy brain': New mothers grew

2010-10-21
WASHINGTON — Motherhood may actually cause the brain to grow, not turn it into mush, as some have claimed. Exploratory research published by the American Psychological Association found that the brains of new mothers bulked up in areas linked to motivation and behavior, and that mothers who gushed the most about their babies showed the greatest growth in key parts of the mid-brain. Led by neuroscientist Pilyoung Kim, PhD, now with the National Institute of Mental Health, the authors speculated that hormonal changes right after birth, including increases in estrogen, ...

New regulator of circadian clock identified

2010-10-21
Montreal, October 20, 2010 – Daily sleeping and eating patterns are critical to human well-being and health. Now, a new study from Concordia University has demonstrated how the brain chemical dopamine regulates these cycles by altering the activity of the "clock-protein" PER2. Published in the Journal of Neuroscience, these findings may have implications for individuals with Parkinson's Disease with disrupted 24-hour rhythms of activity and sleep. "PER2 is a protein well-known for its role in the regulation of daily or circadian rhythms, this is why it is referred to ...

Measuring the electrical properties of nano-crystals

2010-10-21
The UK's National Physical Laboratory (NPL) is working to provide more reliable measurement of the electrical properties of materials used in nanotechnology – which could lead to much more accurate devices in the future. Scanning probe microscopy (SPM) won the Nobel Prize in 1986. It uses a nano-sized probe to feel the surface of a material – akin to a finger reading Braille on an extremely small scale. The technique can also measure the electrical properties of materials used in nanotechnology – and "feel" how the materials react when electricity is passed through it. ...

Microbes may consume far more oil-spill waste than earlier thought

2010-10-21
CAMBRIDGE, Mass., Oct. 20, 2010 -- Microbes living at the bottom of the Gulf of Mexico may consume far more of the gaseous waste from the Deepwater Horizon oil spill than previously thought, according to research carried out within 100 miles of the spill site. A paper on that research, conducted before the Deepwater Horizon rig exploded six months ago today, will appear in a forthcoming issue of the journal Deep-Sea Research II. It describes the anaerobic oxidation of methane, a key component of the Gulf oil spill, by microbes living in seafloor brine pools. "Because ...

Researchers analyze student grief online after campus shootings

Researchers analyze student grief online after campus shootings
2010-10-21
CHAMPAIGN, lll. — After the campus shootings at Virginia Tech in 2007 and Northern Illinois University in 2008, hundreds of affected students turned to social media websites to share their grief and search for solace. A new study of these students found that their online activities neither helped nor harmed their long-term psychological health. The study, which appears in Personality and Social Psychology Bulletin, gives a first-of-its-kind portrait of student reactions to shootings on their campuses. It also documents the (online and off-line) activities they engaged ...

Link between 2 forms of ALS suggests drug target

2010-10-21
For the first time, researchers have discovered a disease mechanism that links hereditary amyotrophic lateral sclerosis to the more common "sporadic" form of ALS -- and points to a possible therapeutic target. The findings are reported online in advance of publication in the journal Nature Neuroscience. ALS is an adult-onset disease that causes progressive degeneration of motor neurons and death within three to five years of diagnosis. Scott Brady, professor and head of anatomy and cell biology at the University of Illinois at Chicago College of Medicine, studies ...

Study identifies barriers to successful treatment of children with sarcoma in low-income countries

2010-10-21
BOSTON––Raising the survival rate of children with sarcoma in low-income countries will require steps to diagnose the disease sooner, train cancer pathologists, expand radiation therapy services, create multi-specialty teams to review each case, and other actions, according to an international study led by Dana-Farber/Children's Hospital Cancer Center researchers. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Friday, Oct. 22. The study explored why, despite advances in the treatment of pediatric ...

Progress toward treating infections by silencing microbes' 'smart phones'

2010-10-21
So disease-causing bacteria in the body finally have multiplied to the point where their numbers are large enough to cause illness. What's next? They get out their "smart phones" and whisper "Let's roll!" That's how an article in ACS' monthly Chemical Reviews describes the substances — "smart phones of the microbial world" — that bacteria use to transmit chemical signals that launch infections and monitor their environment. The authors describe progress toward understanding and blocking this biochemical chitchat, a development that could lead to new treatments for the growing ...

Girls with ovarian germ-cell tumors can safely skip chemotherapy unless disease recurs

2010-10-21
BOSTON – Researchers from Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) have found that as many as 50 percent of young girls treated for germ-cell ovarian tumors might safely be spared chemotherapy using a "watch and wait" strategy to determine if the follow-up treatment is needed. In contrast to the current practice of administering chemotherapy to all patients following removal of these rare tumors, researchers said the study demonstrated that treatment could safely be delayed and given only if the cancer recurred. Data from the trial involving 25 young ...

Biodegradable foam plastic substitute made from milk protein and clay

2010-10-21
Amid ongoing concern about plastic waste accumulating in municipal landfills, and reliance on imported oil to make plastics, scientists are reporting development of a new ultra-light biodegradable foam plastic material made from two unlikely ingredients: The protein in milk and ordinary clay. The new substance could be used in furniture cushions, insulation, packaging, and other products, they report in the ACS' Biomacromolecules, a monthly journal. David Schiraldi and colleagues explain that 80 percent of the protein in cow milk is a substance called casein, which already ...

LAST 30 PRESS RELEASES:

Hot flashes can be reliably predicted by an ai-driven algorithm developed by UMass Amherst and Embr Labs

FAU/Baptist Health AI spine model could transform lower back pain treatment

CDI Lab, HMH specialists identify vital pathway initiating cellular immunity in Science Immunology journal

University of Pennsylvania professor to receive the 2025 Clinical Research Prize

Revolutionary scandium doping technique extends sodium-ion battery life

High-fat diet impairs memory formation by reducing autophagy

Keck Hospital of USC named a Vizient Top Performer for third year in a row

New CRISPR test could make tuberculosis screening as simple as a mouth swab

Three-sensor overeating detection could reshape obesity treatment

Study provides first evidence that plastic nanoparticles can accumulate in the edible parts of vegetables

AI predicts complications from surgery better than doctors

New personalized risk score could improve ovarian cancer detection

People on Ozempic who eat to regulate emotions less likely to lose weight

AACR Cancer Progress Report highlights lifesaving impact of federal investments in cancer research

Indra's internet

Lymph nodes found to be key to successful cancer immunotherapy

Room-temperature terahertz device opens door to 6G networks

A hard look at geoengineering reveals global risks

When smoke signals danger: How Australian lizards evolved to escape fire

Beyond the surface: Atopic eczema linked to significantly higher risk of suicidal thoughts, major study finds

After weight loss regular exercise rather than GLP-1 weight-loss drug reduces leading cause of heart attack and strokes

EASD launches its first ever clinical practice guideline – the world’s first to focus on diabetes distress

Semaglutide provides powerful protection against diabetic retinopathy, the leading cause of blindness in working-age adults, Greek study suggests

Orforglipron taken orally once daily leads to significant body weight loss (ATTAIN-1 Study)

U of I researchers trace genetic code’s origins to early protein structures

Disease experts team up with Florida Museum of Natural History to create a forecast for West Nile virus

Researchers: Targeted efforts needed to stem fentanyl crisis

New UMaine research could help lower prescription drug costs

Molecular movie shows how mitochondria read their DNA

Loss of key male fertility gene leads to changes in expression of hundreds of other genes

[Press-News.org] Hormone therapy increases invasive breast cancer and mortality, WHI 11-year follow up finds
UB to manage $8.2 million to fund new round of WHI studies